From the Glossy Page Blog

There is marked species variation in the effectiveness of the drug, so that although it causes adrenocortical necrosis in the dog, it is inactive in the mouse, rat, monkey, and other animals. Some cytolytic changes have been observed in man. It has been used primarily to treat metastatic adrenocortical carcinoma. There has been some evidence of regression in 25 percent of the patients with producing carcinoma, and rarely in patients with nonfunctioning adrenocortical carcinomas. The side effects of the drug are quite severe, including intolerable nausea, skin rashes, pigmentation, somnolence, nystagmus, blurring of vision, and slurring of speech.Medical Coding Billing Training.will help in the appropiate reimbursement and collections, stay with HIPAA compliance and get more collections.